22 Sep 16 14 Nov 16

MSF Journal Club

The MSF Journal Club is a forum for debate and discussion of articles relevant to our medical humanitarian programmes.

The club brings together MSF programme staff with experts from around the world to keepthem informed of the latest research and opinion around delivering care in resource-limited, emergency.

If you require further assistance or have any questions about the journal club please contact Kim West at kim.west@london.msf.org

When and where?

The journal club meets monthly on Twitter via @MSFsci using the hashtag #MSFjc.

Watch this space to find out when the next journal club will be or sig nup to the mailing list. 

 

New to Twitter?

Twitter is a social media service where users can post 'tweets' that are 140 characters in length. Users can group tweets by any given topic using a "hashtag", which is a hash sign (#) followed by a given word or phrase. 

For the MSF Online Journal Club all tweets should be marked with #MSFjc and this will create a virtual discussion board, enabling all participants to track our conversation. 

Previous journal club discussions

Directly observed therapy for treating tuberculosis / Storify

Classification of antituberculosis drugs: a new proposal based on the most recent evidence / Storify

Optimal Duration of Anti-TB Treatment in Patients With Diabetes: Nine or Six Months?  / Storify

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China / Storify

Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa / Storify

Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities / Storify

Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China / Review / Storify

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine / Review / Storify

Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death  / Review / Storify